Visual Acuity Outcomes in Diabetic Macular Edema With Fluocinolone Acetonide 0.2 μg/Day Versus Ranibizumab Plus Deferred Laser (DRCR Protocol I).
暂无分享,去创建一个
C. Greven | B. Kuppermann | F. Ghanchi | Daniel M Miller | J. Gross | C. Bailey | B. Kapik | M. Singer